Financials

  • Market Capitalization 4.88 B
  • Employee 497
  • Founded 2011
  • CEO N/A
  • Website www.travere.com
  • Headquarter California, United States
  • FIGI BBG000P9D6W9
  • Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-131.76
Rapporto prezzo/fatturato
6.95

Related tickers

#NomePrezzo24h %7d %1M %1Y %Valore di MercatoUltimi 7 Giorni
1295
PTCT
PTC Therapeutics, Inc. - Common Stock
59.92 USD-4.77%-5.17%-10.57%-7.82%5.00 B USD
1309
SRRK
Scholar Rock Holding Corporation - Common Stock
40.52 USD-3.39%-4.16%-28.30%+34.98%4.93 B USD
1316
COGT
Cogent Biosciences, Inc. - Common Stock
28.09 USD-5.67%-6.52%-15.95%+79.26%4.87 B USD
1321
CRSP
CRISPR Therapeutics AG - Common Shares
50.10 USD-2.81%-5.47%-2.57%-25.63%4.84 B USD

Notizie